Use of viral promoters in mammalian cell-based bioassays: How reliable?

被引:2
|
作者
Betrabet S.S. [1 ]
Choudhuri J. [1 ]
Gill-Sharma M. [1 ]
机构
[1] Natl. Inst. for Res. in Repro. Hlth., ICMR, Parel, Mumbai 400 012, Jahangir Merwanji Street
关键词
Reporter Vector; Viral Promoter; Chloramphenicol Acetyl Transferase; Reporter Gene Construct; Human Therapy;
D O I
10.1186/1479-5876-2-1
中图分类号
学科分类号
摘要
Cell-based bioassays have been suggested for screening of hormones and drug bioactivities. They are a plausible alternative to animal based methods. The technique used is called receptor/reporter system. Receptor/reporter system was initially developed as a research technique to understand gene function. Often reporter constructs containing viral promoters were used because they could be expressed with very 'high' magnitude in a variety of cell types in the laboratory. On the other hand mammalian genes are expressed in a cell/tissue specific manner, which makes them (i.e. cells/tissues) specialized for specific function in vivo. Therefore, if the receptor/reporter system is to be used as a cell-based screen for testing of hormones and drugs for human therapy then the choice of cell line as well as the promoter in the reporter module is of prime importance so as to get a realistic measure of the bioactivities of 'test' compounds. We evaluated two conventionally used viral promoters and a natural mammalian promoter, regulated by steroid hormone progesterone, in a cell- based receptor/reporter system. The promoters were spliced into vectors expressing enzyme CAT (chloramphenicol acetyl transferase), which served as a reporter of their magnitudes and consistencies in controlling gene expressions. They were introduced into breast cell lines T47D and MCF-7, which served as a cell-based source of progesterone receptors. The yardstick of their reliability was highest magnitude as well as consistency in CAT expression on induction by sequential doses of progesterone. All the promoters responded to induction by progesterone doses ranging from 10-12 to 10-6 molar by expressing CAT enzyme, albeit with varying magnitudes and consistencies. The natural mammalian promoter showed the most coherence in magnitude as well as dose dependent expression profile in both the cell lines. Our study casts doubts on use of viral promoters in a cell-based bioassay for measuring bioactivities of drugs and hormones for human therapy and suggests caution regardingtranslation in toto, of a research technique as a cell-based bioassay for drug screening. © 2004 Betrabet et al; licensee BioMed Central Ltd.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Cell-based luminescent reporter bioassays for immunotherapies targeting macrophage effector functions
    Mitchell, Jonathan
    Gilden, Julia
    Hartnett, Jim
    Stecha, Pete
    Krishnan, Gopal B.
    Fan, Frank
    Cong, Mei
    Grailer, Jamison
    CANCER RESEARCH, 2023, 83 (07)
  • [32] Discovery of molecular mechanisms of neuroprotection using cell-based bioassays and oligonucleotide arrays
    Sarang, SS
    Yoshida, T
    Cadet, R
    Valeras, AS
    Jensen, RV
    Gullans, SR
    PHYSIOLOGICAL GENOMICS, 2002, 11 (02) : 45 - 52
  • [33] Cell-based assays to identify inhibitors of viral disease
    Green, Neil
    Ott, Robert D.
    Isaacs, Richard J.
    Fang, Hong
    EXPERT OPINION ON DRUG DISCOVERY, 2008, 3 (06) : 671 - 676
  • [34] Electrically regulated cell-based intervention for viral infections
    Newmyer, Sherri
    Ssemadaali, Marvin A.
    Radhakrishnan, Harikrishnan
    Javitz, Harold S.
    Bhatnagar, Parijat
    BIOENGINEERING & TRANSLATIONAL MEDICINE, 2023, 8 (02)
  • [35] Qualification of a Single-Use Disk Stack Separator for Cell Separation in Mammalian Cell-Based Antibody Production
    Ott, Vivian
    Mueller, Jan
    Schirmer, Cedric
    Weiss, Noemi
    Goehmann, Rudiger
    Biewald, Andreas
    Michel, Andrej
    Eibl, Dieter
    Eibl, Regine
    CHEMIE INGENIEUR TECHNIK, 2022, 94 (12) : 1936 - 1943
  • [36] EFFECTS OF NONPHYSIOLOGICAL TREATMENT CONDITIONS ON MAMMALIAN CELL-BASED ASSAYS
    SEEBERG, AH
    MOSESSO, P
    FORSTER, R
    MUTATION RESEARCH, 1987, 182 (05): : 290 - 291
  • [37] Mammalian Cell-Based Immunoassay for Detection of Viable Bacterial Pathogens
    Xu, Luping
    Bai, Xingjian
    Tenguria, Shivendra
    Liu, Yi
    Drolia, Rishi
    Bhunia, Arun K.
    FRONTIERS IN MICROBIOLOGY, 2020, 11
  • [38] Practical and regulatory considerations in the development of mammalian cell-based biopharmaceuticals
    Moore, W. Alan
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2005, 41 : 22A - 22A
  • [39] West African e-waste-soil assessed with a battery of cell-based bioassays
    Eze, Chukwuebuka ThankGod
    Otitoloju, Adebayo Akeem
    Eze, Obianuju Oluchukwu
    Ugochukwu, Tochukwu Ernest
    Onodugo, Chinemelum
    Ali, Aasim Musa
    Lyche, Jan Ludvig
    Karlsen, Odd Andre
    Goksoyr, Anders
    SCIENCE OF THE TOTAL ENVIRONMENT, 2023, 856
  • [40] QUANTITATIVE CELL-BASED BIOASSAYS TO ADVANCE IMMUNOTHERAPY PROGRAMS TARGETING IMMUNE CHECKPOINT RECEPTORS
    Grailer, Jamison
    Gilden, Julia
    Stecha, Pete
    Garvin, Denise
    Wang, Jun
    Beck, Michael
    Hartnett, Jim
    Krishnan, Gopal
    Fan, Frank
    Cong, Mei
    Cheng, Zhi-Jie
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A468 - A468